TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: interhemispheric connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Waist-to-Height Ratio (WHtR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: illicit opioid abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of successful weaning from mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Back/leg pain severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percentage of prescriptions compliant with indication
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean percentage of prescriptions compliant with choice regarding antibiotics prescribed for prophylactic reasons
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Management change secondary to PET/CT
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: navigation performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median linear wear rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: revision due to loosening
Endpoint domain: Adverse events/effects
Primary endpoint: liner fracture
Endpoint domain: Adverse events/effects
Primary endpoint: symptomatic corrosion
Endpoint domain: Adverse events/effects
Primary endpoint: 24-hour piritramide consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-first analgesic request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rates of postsurgical pressure injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: WRSD score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year cardiovascular mortality (CVM)
Endpoint domain: Mortality/survival
Primary endpoint: frailty as assessed by SPPB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GV attendance rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average number of GVs attended
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: not currently smoking at the five-year follow-up
Endpoint domain: Mortality/survival
Primary endpoint: DLQI score decline
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient-Rated Wrist Evaluation score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Need for surgical fixation for loss of fracture position
Endpoint domain: Adverse events/effects
Primary endpoint: DQ scores of adaptation, fine motor and social
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean glycated hemoglobin (% HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of participants achieving glycemic control (HbA1c < 7%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total QoR-40 score at T6
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: VAS-satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood Glucose Levels (BGL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: PICU days
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Pain domain improvement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Intention to discuss clinical trials with patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: neuromuscular control of the deep cervical flexors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Degree of anxiety before and after surgery
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: change in lean mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: proportion of weight loss as fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean pain intensity with the VAS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily intake of vegetables
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: daily intake of saturated fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: behavior change
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Rate of Fever Post-Bronchoalveolar Lavage (BAL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in patient global assessment by visual analogue scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in the 6-min walk test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Geographic access to foods prepared away from home
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HEI-2015 scores for retailers' full menus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of severe postspinal anesthesia hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: MS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain scores during colonoscopy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in total TRL particle concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Increase in small HDL particle concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: Change in large LDL particle concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lipid outcomes
Primary endpoint: time to first stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: hours of formal care missed
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: days of informal care increase
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: reduction in home nursing service
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Pancreatic necrosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Height Standard Deviation Score (HT-SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin-like Growth Factor 1 (IGF-1) Standard Deviation Score (IGF-1 SDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HBI recovery trajectory group membership
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mentally unhealthy days
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: chronic disease self‐efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Proportion of overeating episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Disinhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ridge width gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total testosterone change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Luteinizing hormone (LH) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Follicle-stimulating hormone (FSH) change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: neurotoxicity scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Acceptability of nutrition care delivery methods
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: ≥50% CLBP relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CLBP resolution (VAS ≤ 2.5 cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in ODI of ≥20 points
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-Oriented Eczema Measure improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Children's Dermatology Life Quality Index improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SCORing Atopic Dermatitis Visual Analog Scale for sleep loss improvement
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mean reduction in serum HBV DNA after 28 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: User satisfaction with mHealth solution
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: speed test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: offering hearing dysfunction assessed with DPOAEs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Prevalence of sensitisation to aeroallergens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Clearance of HPV genotypes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DGI score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF‐36 mental composite score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Acceptance of HIV self-testing kit offer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported taking an HIV self-test within the past 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reported drinking fewer glasses of alcohol in an average week
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Median number of attempts to achieve successful cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety and efficacy of Lu-PSMA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate and severity of delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fidelity to Dignity Therapy delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parents' physical literacy knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Parents' confidence
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in myocardial injury outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fascicle length of RF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Instructor adherence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Instructor competency score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TSI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spiegel scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: SDS score (depression)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Threat-related amygdala reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mPFC activation during threat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: mPFC-amygdala functional coupling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: time to maximal concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of CAUTIs
Endpoint domain: Adverse events/effects
Primary endpoint: Catheter tip culture test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: hyperactivity-impulsivity symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cesarean delivery rates
Endpoint domain: Adverse events/effects
Primary endpoint: Labor duration >24 hours
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal hospitalization >3 days
Endpoint domain: Adverse events/effects
Primary endpoint: METS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in trained items
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in untrained words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: endline lymphocyte concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: eosinophil concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: functional coupling between the amygdala and the prefrontal cortex
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cumulative probability of developing CI-DME with vision loss or PDR
Endpoint domain: Mortality/survival
Primary endpoint: Change in visual acuity from baseline to 2 years
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Death within 6 months of surgery
Endpoint domain: Mortality/survival
Primary endpoint: trunk range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary Symptom Questionnaire for Neurogenic Bladder (USQNB) bladder and urine symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: episodes of presumed UTIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: days of work, school, rehabilitation, or other activity lost due to urinary symptoms
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Probability of the presence of vulnerable carotid plaque
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ILRR (Initial Lesion Response Rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Healthier selections
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MLSI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Bell's palsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rate of Bell's palsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean composite standardised PARCA-R scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative back pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interval from surgery to autonomous mobilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to 1st rescue analgesics request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pediatric objective pain scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Advance directive documentation
Endpoint domain: Physiological/clinical
Primary endpoint: ACP engagement scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: risk of fragility fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean pain score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cumulative active TB rate
Endpoint domain: Mortality/survival
Primary endpoint: Completion rate of the 3RPT/INH regimen
Endpoint domain: Adverse events/effects
Primary endpoint: Conscious rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CRS-R score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: attention and working memory
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: metabolic complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ovarian Sensitivity Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Grade 3 or worse treatment-related toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Sedentary behavior monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Moderate activity monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vigorous activity monitoring
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Freedom from CAV
Endpoint domain: Mortality/survival
Primary endpoint: Freedom from NF-MACE
Endpoint domain: Mortality/survival
Primary endpoint: Development of involutional blepharoptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of treatment-related grade 3-4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Induction of disease remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in LBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of significant IVH (grades II, III, and IV)
Endpoint domain: Adverse events/effects
Primary endpoint: Mean initial hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: volumetric socket variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pupillary response to threat words
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-reported vigilance
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Grip termination time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worsening heart failure or cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: eating disorder examination global score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pressure values improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease of understanding information
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Quality of evaluation of information explained
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: cost-effectiveness of morphine treatment
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: minimal clinically important difference of 2 points increase in CAT score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: QALY
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cumulative incidence of probable/proven IFI at day 60
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of AML complete remission
Endpoint domain: Physiological/clinical
Primary endpoint: Reduction in daytime systolic ABP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in 24-h systolic ABP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in brachial artery flow-mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prefrontal–frontal EEG-based connectivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall satisfaction with delivering buprenorphine treatment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Counts of lymphocyte subsets
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: comfort
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: autonomy
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Discharge difficulties
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: SF-NDI symptom scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-NDI quality of life scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fear of Childbirth (FOC) scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Childbirth Self-Efficacy Index (CBSEI) scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Postprocedural pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Longest apnoea duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: HM concentrations of DHA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HM concentrations of EPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AA/(DHA + EPA) ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Yale-Brown Obsessive Compulsive Scale compulsion score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 2-h postprandial blood glucose/glycosylated hemoglobin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes